CompoAtlas

FOCUS

Food supplement declared in France, declaration No 2022-3-1358, decision dated 28 March 2022

FOCUS is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
1337 PHARMA SAS
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
2 gélules par jour
Directions for use
Prendre 2 gélules par jour
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes, Sous anticoagulants, Sous antidépresseurs
Objectives stated by the manufacturer (these are not authorised claims)
Concentration

Declaration 183206, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Bacopa monnieri (L.) Wettst.FeuilleExtrait sec hydroalcoolique500 mg
Ginkgo biloba L.FeuilleExtrait sec hydroalcoolique120 mg
Paullinia cupana KunthGraineExtrait sec aqueux75 mg
Aronia melanocarpa (michx.) ElliotFruitExtrait sec hydroalcoolique65 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Sulfate de cuivreCuivre5,000 µg2,000 µg
Chlorhydrate de pyridoxineVitamine B612 mg2 mg

Additives

E470b

Other ingredients

Gélule végétale

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2022. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

Label warnings

Consultez votre médecin en cas de prise simultanée d'anticoagulants. L’emploi chez les femmes enceintes et allaitantes ainsi que chez les personnes sous traitement antidépresseur est déconseillé.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line